Skip to contentK
Kewaunee Scientific Corp
K
KEQUKewaunee Scientific Corp Q3 2024 · 10-Q
Revenue$46.78M$46.78M−23.1% vs Q3 2023 Net Income$2.52M$2.52M+248.7% vs Q3 2023 EPS Diluted$0.85$0.85+240.0% vs Q3 2023 Gross Profit$12,029,000+16.4% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Kewaunee Scientific Corp · CIK 55529 · Engraved from SEC EDGAR
Operating Cash Flowderived$9,500,000N/M Free Cash Flowderived$9,025,000N/M Margins · derivedGross margin25.7%+8.7 pt vs Q3 2023
Operating margin8.1%+4.3 pt vs Q3 2023
Net margin5.4%+4.2 pt vs Q3 2023
ended Jan 31, 2024 · filed Mar 8, 2024 · 37 d after period end